文献速递角膜与眼表疾病

多重耐药性角膜炎:棘手但可处理

Multidrug-resistant keratitis: challenging yet manageable.
PubMed 文献 · Br J Ophthalmol · 2022-03-28

回顾性分析2年内40例多重耐药(MDR)细菌性角膜炎患者,最常见危险因素是植物性外伤(30.0%)。15例(37.5%)仅用药物治疗即完全消退,5例(12.5%)行治疗性穿透性角膜移植术。浸润灶大小与结局显著相关(p=0.002)。作者认为早期启动适当治疗可仅用药物成功处理。

要点

  • 最常见危险因素为植物性外伤(n=12,30.0%),其次为角膜移植(n=7,17.5%)和全身合并症(n=7,17.5%)。
  • 对3类(n=17,42.5%)和4类(n=17,42.5%)抗生素耐药最常见,1例(2.5%)对全部7类测试药物耐药。
  • 15例(37.5%)仅药物治疗即完全消退,5例(12.5%)行治疗性穿透性角膜移植术。

核心结论

  • MDR角膜炎尽管治疗棘手,若在临床病程早期启动适当治疗,可仅用药物治疗成功处理。

研究设计与样本

  • 回顾性分析2年内就诊于本研究院的所有MDR细菌性角膜炎病例,共40例。
  • 记录危险因素、浸润灶大小和深度、治疗及结局,并对眼部分离株行抗生素药敏试验。

主要发现

  • 患者平均年龄50.9±25.4岁。
  • 浸润灶<6 mm者22例(55%),>6 mm者18例(45%)。
  • 浸润累及浅层、中层和深层基质者分别为11例(27.5%)、9例(22.5%)和15例(37.5%)。
  • 革兰阴性杆菌最多(n=18,45%),其中铜绿假单胞菌最常见(15%)。
  • 浸润灶大小与结局显著相关(p=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To study the incidence, clinical features and outcomes of multidrug-resistant (MDR) bacterial keratitis. METHODS: All cases of MDR-bacterial keratitis presenting to our institute over a period of 2 years were retrospectively analysed. Details of risk factors, size and depth of infiltrate, treatment, and outcome were noted. Antibiotic susceptibility tests were done on the ocular isolates from the culture of samples obtained from ocular infections, and resistance or sensitivity of the organisms to the commonly used antibiotics was studied. RESULTS: Forty patients were diagnosed with MDR-bacterial keratitis in the study period. The mean age of patients was 50.9±25.4 years. Most common risk factors were vegetative trauma (n=12, 30.0%), followed by corneal transplantation (n=7, 17.5%) and systemic comorbidities (n=7, 17.5%). Infiltrate was small (<6 mm) in 22 (55%) and large (>6 mm) in 18 (45%) patients. It involved the superficial, mid and deep stroma in 11 (27.5%), 9 (22.5%) and 15 (37.5%) cases, respectively. Gram-negative bacilli (n=18, 45%) were the maximum, among which Pseudomonas aeruginosa (15%) was the most common. Resistance to 3 (n=17, 42.5%) and 4 (n=17, 42.5%) classes of antibiotics was the most commonly observed. One (2.5%) patient showed resistance to all seven classes of drugs tested. Complete resolution of infection was seen in 15 (37.5%) MDR patients on medical management alone. Five (12.5%) patients underwent therapeutic penetrating keratoplasty. Size of the infiltrate was found to have a significant correlation with the outcome (p=0.002). CONCLUSION: MDR keratitis, despite being a challenge to treat, can be successfully managed by medical therapy alone, if appropriate therapy is started early in the clinical course.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sahoo S, Alluri H, Mitra S, et al. Multidrug-resistant keratitis: challenging yet manageable. Br J Ophthalmol. 2022. PMID: 35346947. doi:10.1136/bjophthalmol-2021-320203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。